Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using ...

Conroe-based bio-tech company VGXI Inc. has defaulted on its tax abatement agreement with Montgomery County and will pay more ...

A University of Bristol spinout that has developed a supplement to support people with Irritable Bowel Syndrome (IBS) has reached a major milestone. The biotech company Ferryx, which launched its ...

Demy-Colton's BioFuturetm 2025 conference wrapped up in New York and virtually this week, sounding a positive tone for the biotech industry and the technologies and trends transforming the future of ...

Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Kirk was speaking on his show, "The Charlie Kirk Show," on July 13, 2023. He was talking specifically about television presenter Joy Reid; former first lady Michelle Obama; then-U.S. Rep. Sheila ...

IM1240, the first CAPTN-3 tri-specific antibody targeting the novel tumor-associated antigen 5T4, advances toward first-in-human clinical trials, with an Investigational New Drug (IND) submission ...

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...